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ABSTRACT
Defects in the ability to respond properly to an un-
repaired DNA lesion blocking replication promote
genomic instability and cancer. Human HLTF, im-
plicated in error-free replication of damaged DNA
and tumour suppression, exhibits a HIRAN do-
main, a RING domain, and a SWI/SNF domain facili-
tating DNA-binding, PCNA-polyubiquitin-ligase, and
dsDNA-translocase activities, respectively. Here, we
investigate the mechanism of HLTF action with em-
phasis on its HIRAN domain. We found that in cells
HLTF promotes the filling-in of gaps left opposite
damaged DNA during replication, and this postrepli-
cation repair function depends on its HIRAN domain.
Our biochemical assays show that HIRAN domain
mutant HLTF proteins retain their ubiquitin ligase,
ATPase and dsDNA translocase activities but are im-
paired in binding to a model replication fork. These
data and our structural study indicate that the HIRAN
domain recruits HLTF to a stalled replication fork, and
it also provides the direction for the movement of the
dsDNA translocase motor domain for fork reversal.
In more general terms, we suggest functional simi-
larities between the HIRAN, the OB, the HARP2, and
other domains found in certain motor proteins, which
may explain why only a subset of DNA translocases
can carry out fork reversal.
INTRODUCTION
Unrepaired DNA lesions can block the movement of
the replication machinery leading to DNA strand breaks
and chromosomal rearrangements providing eventually the
driving force to cancer (1). To minimize these consequences,
cells possess distinct mechanisms for replicating through
damaged DNA such as translesion synthesis or template
switching (2–4). During translesion synthesis, one of the
low-fidelity translesion synthesis (TLS) polymerases takes
over the primer 3′-end from the stalled high-fidelity replica-
tive polymerase and incorporates either a correct or an in-
correct nucleotide opposite the damaged base (5). In or-
der to do so, TLS polymerases exhibit flexible active sites,
which enable them to cope with various damaged bases on
the template (6). However, not all types of lesions in the
template strand can be accommodated into the active site
of TLS polymerases, and thus they cannot provide a gen-
eral solution for replication through all types of DNA dam-
age (2,7). The other drawback of TLS polymerases is that
they frequently generate mutations. By contrast, template
switching provides a more universal solution for the by-
pass of a wide variety of lesions with the undoubted ad-
vantage of operating in an inherently error-free mode. A
prerequisite of template switching is the uncoupling of the
leading and lagging strand synthesis resulting in the leading
strand stalled at the lesion and the lagging strand synthe-
sis going on. Next, remodelling of the stalled nascent lead-
ing strand from the damaged template to the newly syn-
thesized strand of the undamaged sister duplex results in
a new primer/template structure where a canonical DNA
polymerase can extend the primer without encountering the
damage (8–10). Depending on the intermediate DNA struc-
ture, two alternative mechanisms have been proposed for
template switching. The first includes a D-loop intermedi-
ate similar to the one proposed for recombination and the
other is the so called ‘chicken foot’ model termed after the
shape of the intermediate DNA structure. To generate the
four-stranded chicken foot, both the leading and the lagging
nascent strands at the replication fork should be displaced
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from the original leading and lagging strand templates and
paired together by the reversal of the replication fork (11).
The discovery of the fork reversal activity of yeast Rad5
and the conclusion that this activity is for mediating error-
free lesion bypass was in keeping with genetic observations
made with various rad5 mutations (12–15). First, epista-
sis analysis revealed that RAD5 belongs to the so-called
RAD6-RAD18 epistasis group of the DNA damage toler-
ance pathway, in which it constitutes an error-free branch
in addition to the two other TLS polymerase-dependent
branches. Deleting RAD5 inactivates the majority of tem-
plate switching-dependent damage bypass in yeast cells in-
dicating that Rad5 is a main player in fork rescue via tem-
plate switching (3,12). Besides Rad5, Mph1 is also shown to
mediate replication fork reversal (16,17). Human cells con-
tain two RAD5 homologues, HLTF and SHPRH, which
supress mutagenesis in a damage-specific manner (18–21).
Furthermore, HLTF and SHPRH are frequently inacti-
vated in various cancers, and their loss increases the fre-
quency of chromosome abnormalities during DNA dam-
age indicating their importance in the maintenance of ge-
nomic stability and cancer suppression (22). Of the two
human homologues, only HLTF exhibits all the main mo-
tifs and enzymatic activities of Rad5. First, depending on
its RING domain, HLTF acts as a ubiquitin ligase stimu-
lating Mms2-Ubc13-dependent Lys-63-linked polyubiqui-
tylation of PCNA after its monoubiquitination by Rad6–
Rad18 at its K-164 residue (20,23). Furthermore, HLTF
exhibits a SWI/SNF helicase domain enabling a dsDNA-
dependent ATPase activity for translocation on dsDNA
(24). In the course of translocation on DNA, HLTF can
displace DNA-bound proteins providing a protein-clearing
function at the stalled replication fork (25). Also, HLTF can
promote strand invasion and formation of a D-loop struc-
ture (26). Finally, depending on the SWI/SNF helicase do-
main, HLTF has a replication fork reversal activity to gener-
ate chicken foot for template switching (24). While the bio-
chemical features and the in vivo significance of the RING
and the SWI/SNF domains of HLTF have been character-
ized, much less is known about its HIRAN domain. The
HIRAN domain can also be found in bacteria, as a stan-
dalone protein or fused to other catalytic domains such
as phosphoesterases or nucleases and is suggested to be a
DNA-binding domain able to recognize 3′-end of ssDNA
(27–29). Nevertheless, to what extent the HIRAN domain
contributes to the DNA damage tolerance function has re-
mained unknown.
Although RAD5 is known to be a dominant player in
yeast postreplication repair (PRR) (3,12), the role of HLTF
and the degree of its contribution to human PRR has not
been clarified. Postreplication repair ensures the full com-
pletion of the replication by facilitating the conversion of
discontinuities left in the newly synthesised strand during
replication to continuous chromosomal DNA. In particu-
lar, PRR has a critical role in the replication of damaged
DNA since single-strand gaps are frequently formed oppo-
site the damaged DNA. PRR is not necessarily S-phase-
specific since the gap filling process can operate even in the
G2-phase of the cell cycle, but completion of the cell cy-
cle without complete PRR may lead to genome instability
and cancer (30). In spite of the active interest and the sig-
nificant investigative efforts, relatively little is known about
PRR in human cells, and its main players remain to be
elucidated. Since the discovery of the fork reversal activity
of Rad5/HLTF, other SWI/SNF enzymes such as SMAR-
CAL1, ZRANB3, and Rad54 have been described to exhibit
similar activities, but the number of enzymes that are able
to carry out fork reversal has remained limited despite the
SWI/SNF protein family having numerous members (31–
33). The E. coli RecG, yeast Mph1, human FANCM heli-
case, and certain RecQ helicases such as WRN and BLM
can also carry out fork reversal (11,34). However, there is
a main mechanistic difference between the dsDNA translo-
cases such as the SWI/SNF enzymes and the canonical heli-
cases in the mechanism of fork reversal since the SWI/SNF
helicase-like proteins do not generate ssDNA intermediates.
Instead, their dsDNA translocase activity drives the simul-
taneous unwinding and annealing of the nascent strands
and the parental strands in the replication fork which en-
sures that the stalled replication forks are not processed to
abortive structures. Despite accumulating data, the basis of
the differences in fork reversal activities and the answer to
what enables the fork reversal activity of a particular DNA
translocase or helicase enzyme as well as the in vivo contri-
bution of these activities to PRR is still unknown.
Here, we examine the in vivo role of HLTF in PRR and
characterise the importance of its various protein domains
in this process with a focus on its HIRAN domain. To pro-
vide structure/function insights, we carry out biochemical
assays such as fork reversal, DNA translocase, PCNA ubiq-
uitylation, and structure-specific DNA binding using puri-
fied wild-type and mutant HLTF proteins. Our observations
provide strong support for the role of HLTF in PRR, clarify
further the function of the HIRAN domain, and explain in




To obtain HLTF with the HIRAN domain deleted
(HLTF156–1009), the 156–589 amino acid region of HLTF
was PCR amplified from pIL1867 (HLTF pENTR2B) us-
ing oligonucleotides O2515 (AAG AAT TCT GGA TTG
GAG TAC) containing an EcoRI restriction site and O2522
(ACG CGT CGA CGC AAT AGA AAA GCG GTT
TCA GAT CAG) containing a SalI site. The PCR frag-
ment was cloned into pIL1867 EcoRI-SalI sites result-
ing in pIL2106, and subsequently the C-terminal part
of HLTF was cloned from pIL1867 into pIL2106 using
EcoRI-EcoRI digestion resulting in pIL2108 (HLTF HI-
RAN del pENTR2B). The wild-type HIRAN domain frag-
ment was PCR amplified from pIL1867 using the oligonu-
cleotides O2603 (TTT CCA TGG ATT CCG TTT TAT
TTG GAA GTT TGA G) containing an NcoI restric-
tion site and O2604 (TTT CTC GAG TCC ATG TTT
CTT CAA CTG ATC TG) containing an XhoI site. The
PCR product was cloned into pIL1163 (pENTR4) with
NcoI-XhoI digestion resulting in pIL2174 (HIRAN do-
main pENTR4). For the HIRAN domain NN90,91AA
point mutant fragment, mutagenic PCR was performed us-
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GCC CCT TAT GAT AAG) and O2733 (CTT ATC ATA
AGG GGC AGC AGG ATC TCG TTG) resulting in
pIL2734 (HIRAN domain 90/91 pENTR4). Yeast expres-
sion constructs were generated using the LR recombination
system and the pIL1844 (pBJ842 GST-FLAG-Destination)
vector resulting in plasmids pIL1520, pIL2111, pIL2177,
pIL2735 expressing the GST-FLAG-HLTF, GST-FLAG-
HLTF159–1009, GST-FLAG-HIRAN domains, and the
mutant GST-FLAG-HIRAN NN90,91AA domain, respec-
tively. The crystallization construct of the HIRAN domain
(aa 56–175) was cloned from a cDNA template from the
Mammalian Gene Collection (hltf.BC044659.MGC.AT70-
E3.pCMV-SPORT6) into the pET28a-LIC vector (Gen-
Bank accession EF442785) using the In-Fusion CF Dry-
Down PCR Cloning Kit (Clontech 639605).
Protein purification
HLTF, MMS2-UBC13, RFC, UBA1, ubiquitin and
monoubiquitylated PCNA were purified as described
previously (35). HIRAN domains were purified similarly
to HLTF using PreScission protease which cleaves between
the GST and FLAG tags resulting in a FLAG-HIRAN
domain, or using 20 mM reduced glutathione resulting in
GST-FLAG-HIRAN.
Protein needed for X-ray structural determination was
purified as follows. Bacterial pellets were obtained from 2-l
LB media initially cultured at 37◦C to an OD600 = 1.0, after
which cells were induced with 1 mM IPTG for 16 h at 15◦C.
Then the bacterial pellets where sonicated and the cleared
cell lysate in lysis buffer (50 mM HEPES, pH 7.5, 500 mM
NaCl, 2.5 mM imidazole) was loaded onto a 5 ml TALON
metal-affinity resin column equilibrated in wash buffer (50
mM HEPES, pH 7.5, 500 mM NaCl, 15 mM imidazole)
at 4◦C temperature. The column was washed with 50 ml of
wash buffer and the protein was eluted with 10 ml of elution
buffer (50 mM HEPES, pH 7.5, 500 mM NaCl, 250 mM
imidazole). Upon addition of 1 unit of Thrombin protease,
2 mM -mercaptoethanol, the eluant was incubated for 10
h at 4◦C. The protein was further purified by gel filtration
on a HighLoad Superdex 75 column equilibrated with Gel-
filtration Buffer (20 mM sodium phosphate pH 6.3 and 100
mM NaCl). Fractions containing protein were pooled and
concentrated using Amicon Ultra centrifugal filter with 3
kD cutoff membrane to a final concentration of 16 mg/ml.
Protein yield was 7 mg/l of bacterial culture.
HIRAN domain (hHLTF.56–175) crystallization
Crystals were grown at 18oC in hanging-drop plates (Hamp-
ton, HR3-170) by mixing 2 l of protein mix (hHLTF.56–
175 (7 mg/ml) and 2 l of crystallization buffer (0.1 M
sodium acetate trihydrate pH 5.0, 40% (v/v) 2-methyl-2,4-
pentanediol).
HIRAN domain (aa 52–171) X-ray structure determination
Diffraction data was collected at beam-line 19ID at the Ad-
vanced Photon Source (APS) synchrotron at Argonne Na-
tional Laboratory. All data sets were integrated and scaled
using XDS (36). The structure was solved by molecular re-
placement using PHASER (search model 4XZF) followed
by iterative model building using Coot (37) and maximum-
likelihood refinement using REFMAC5. Statistics of data
collection, processing, and refinement are provided in Sup-
plementary Table S01.
DNA substrates
We have previously described the generation of the
plasmid-sized replication fork model substrate and the
triple-helix substrate (24). To generate oligonucleotide-
based DNA substrates, we annealed oligonucleotides
in various combinations followed by purification
from polyacrylamide gel. The oligonucleotide-based
substrates were the following: O1358 (ss42-mer),
O1058/O1118 (ds75-mer), O1054/O1118 (partial
duplex), O1054/O1056/O1058/O1118 (fork) where
the 5′ 32P-labeled oligonucleotides are underlined,
and O3063 (ss75-mer), O3063/O1054 (ds75-mer),
O1054/O1056/O1058/O3063 (fork), where O3063 is a
5′ fluorescein-labeled oligonucleotide with a sequence
identical to O1118.
























PCNA polyubiquitylation, fork reversal, triple-helix dis-
placement and in vitro assays
A standard in vitro ubiquitination reaction was carried out
as described previously (20) for 1 h at 37◦C using purified
HLTF proteins at 20 nM concentration.
ATPase assay (10 l) was performed in buffer A con-
taining 20 mM Tris–HCl pH 7.0, 1 mM MgCl2, 10 mM
KCl, 60 g/ml BSA, 1 mM DTT, and 10% glycerol using
5–20 nM HLTF proteins, 1 mM [ -32P]ATP and 1 M
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37◦C for 30 min, 2 l of each sample were spotted onto PEI
cellulose F thin layer chromatography plate (Merck), fol-
lowed by resolving the products using a solvent containing
1 M formic acid and 0.25 M LiCl. Products were detected
using Typhoon Trio imager.
Fork reversal and triple-helix displacement assays were
carried out as described previously (24). Briefly, reactions
were carried out in buffer B containing 20 mM Tris–HCl,
pH 7.0, 150 mM NaCl, 5 mM MgCl2, 5 mM ATP, 0.1
mg/ml bovine serum albumin, 1 mM DTT, and 10% glyc-
erol with 0.5 nM 32P-labeled substrate DNA and HLTF
protein in 5–20 nM concentration for 10 min at 37◦C. After
incubation, equal volumes of helicase stop buffer contain-
ing 20 mM EDTA, 2 mg/ml proteinase K, 1% sodium dode-
cyl sulfate, 10% glycerol, and 0.02% bromphenol blue were
added followed by incubation for 5 min at 37◦C. Samples
were loaded onto 10% native polyacrylamide gels, and the
products were separated using 1× Tris-borate buffer con-
taining no EDTA. Assays with the plasmid-sized forks were
carried out as described above, but restriction enzyme diges-
tion was carried out before electrophoresis.
Gel shift and DNA competition assays
Gel shift assays were carried out as described previously
(25). For the DNA competition assay, first GST-FLAG-
HIRAN was bound to the Cy5-labeled fork at a concen-
tration where 95% of the DNA was bound by the HIRAN
domain in binding buffer containing 20 mM HEPES 7.5,
150 mM NaCl, 1 mM DTT, 0.1 g/mL BSA, 0,2% NP40,
and 10% glycerol at room temperature for 15 min. Next,
the protein-bound DNA substrate was divided and used
immediately for the competition assay, in which increasing
amounts of competitor fluorescein-labeled DNA substrates
(0–1 M) were added, followed by incubation at room tem-
perature for 15 min. Samples in 0.5× Tris-borate buffer and
2.5% glycerol were loaded onto a 6% native polyacrylamide
gel containing acrylamide and N,N-bis-acrylamide in 30:0.8
ratio and electrophoresed at 4◦C in 0.5× Tris-borate buffer
containing no EDTA, followed by visualization and analy-
sis using Typhoon Trio Imager and its software.
Cell culture assays
HCT116 human cells were grown in Dulbecco’s modi-
fied Eagle’s medium (Sigma) supplemented with 10% FCS
(Sigma) at 37◦C. Transfections were carried out using Lipo-
fectamine 2000 transfection reagent (Invitrogen) according
to the instructions of the manufacturer. To generate HLTF-
specific shRNA-silenced stable cell lines, we cloned the
HLTF-specific DNA sequences O2611 (GAT CCC CGG
TGC TTT GGC CTA TAT CAt tca aga gaT GAT ATA
GGC CAA AGC ACC TTT TTG GAA A) and O2612
(AGC TTT TCC AAA AAG GTG CTT TGG CCT ATA
TCA tct ctt gaa TGA TAT AGG CCA AAG CAC CGG
G) into the HindIII site of the shRNA-Neo plasmid, result-
ing in pIL2394. Next, the silencing plasmid was transfected
into HCT116 cells, followed by selection using G-418 SUL-
PHATE (Gibco, cat. no.: 11811064) to obtain stable cell
lines.
The cellular localization of expressed FLAG-HLTF WT
and HIRAN domain mutant proteins was analyzed by
immunostaining using anti-Flag antibody (Sigma) diluted
1:300 and Cy3-conjugated anti-mouse antibody (Sigma,
cat. no.: C2181) diluted 1:1000. Samples were mounted in
phosphate-buffered saline (PBS) containing 25% glycerol
and 1 mg/ml DAPI, followed by microscopy using an Olym-
pus FV1000 confocal laser scanning microscope and a Leica
confocal LSM.
Sensitivity assay
A cell competition-based UV sensitivity assay was per-
formed as described earlier (35,38). Briefly, after 24 h of
transfection of wild-type and mutant HLTF expressing
plasmids the cells were mixed with stable GFP-expressing
HeLa cells at a ratio of 1:1 and UV-irradiated for 16h. Af-
ter 7 days of culturing, the ratio of GFP-negative and GFP-
positive cells (surviving cells) was determined by FACS
(Guava Easy site System).
Comet assay
The BrdU comet PRR assay was performed according to
our previously published method (39). Briefly, cells were
transfected for 5 h using 8 l LipofectamineTM2000 (In-
vitogen) reagents mixed with 5 l plasmid DNA in 6-well
plates, according to the manufacturer’s instructions. After
24 h, asynchronously growing cells were pulse-labeled with
BrdU for 20 min, washed with PBS, divided into two parts,
and irradiated with UV or mock-treated. This labelling al-
lowed us to follow the PRR process exclusively in S-phase
cells. Next, cells were left to recover in a chasing medium
supplemented with 4× dNTP for 6 h. Cells were collected by
typsinization, pelleted in PBS, resuspended in low melting
point agarose at 37◦C and layered onto agarose-precoated
frosted microscope slides. Proteins were removed by lysis in
2.5 M NaCl, 100 mM EDTA, 10 mM Tris [pH 10], 1%Triton
X-100, and 0.5% N-lauroylsarcosine sodium salt. Alkaline
electrophoresis was conducted in ice-cold electrophoresis
buffer (0.3 M NaOH, 1 mM EDTA, pH 13) at 25 mA for 25
min. Slides were neutralised (0.4 M Tris-HCl, pH 7.4) and
blocked in PBS containing 0.1% BSA and 0.1% Tween20
for 30 min. Immunostaining was performed by layering
30 l of rat monoclonal anti-BrdU antibody (1:750, Ab-
Direct Serotech) for 90 min followed by staining with Alexa
Fluor 488-labeled goat anti-rat antibody (1:750, Molecular
Probes, Inc.) for 2 h. Slides were analyzed by Zeiss Axio-
scope fluorescent microscopy and measured by Komet 5.0
(Kinetic Imaging Ltd, Liverpool, UK).
RESULTS
Structural determinants of HLTF function
HLTF has three well-described domains, namely, the HI-
RAN domain, the SWI/SNF domain, and the C3HC4-type
RING finger domain (Figure 1A). To gain more insight into
the structural determinants of HLTF function, we first used
computational sequence analysis and structural modeling.
Computational sequence analysis suggested that the N-
terminal region (∼50 residues) of HLTF preceding the HI-
RAN domain is mostly disordered. The linker between the
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Figure 1. The effect of HIRAN deletion on cellular function of HLTF. (A) Domain structure of the HLTF protein. The SNF2-type ATPase-helicase, the
C3HC4-type RING finger domain and the HIRAN motif are shown by gray boxes numbered I–VI, a black box, and a striped box, respectively. In HLTF
156–1009, the N-terminal 155 amino acids containing the whole HIRAN domain were deleted, in HLTF NN90,91AA the two asparagines in position 90
and 91 were mutated to alanines. (B) Multiple alignment of the HIRAN domain. Conserved residues are shaded, and asterisks indicate residues mutated
to generate HLTF NN90,91AA. (C) The crystal structure of the HIRAN fragment (hHLTF.56–175) with a dinucleotide fragment reveals a six-stranded
-barrel covered with two -helices. The DNA-binding site of the HIRAN domain is positioned in a cavity region formed by two loops and one -strand.
(D) Deletion or mutation of the HIRAN domain of HLTF sensitises cells to UV irradiation. Complementation of the UV sensitivity of stable shRNA-
depleted HLTF knockdown HCT116 cells was tested by expressing the shRNA-resistant form of WT (HLTF WT), RING mutant (HLTF C759S), ATPase
mutant (HLTF DE557,558AA), HIRAN deletion mutant (HLTF 156–1009), and HIRAN point mutant (HLTF NN90,91AA) HLTF proteins.
to be largely disordered indicating that the orientation be-
tween HIRAN and the SWI/SNF2 domain might be flexi-
ble. The HLTF SWI/SNF2 region features two insertions:
the RING finger domain and a long lysine/serine-rich inser-
tion (∼320–460). This latter insertion of unknown structure
features several regions of intrinsic disorder with protein-
binding propensity suggesting a possible role in mediating
protein-protein interactions. In contrast to the conserved
RING finger domain, this sequence is missing in many
homologs including both budding and fission yeast Rad5.
Alignment of the HIRAN domains present in various pro-
teins (Figure 1B) revealed its highly conserved residues,
and our model indicated that the HIRAN domain is a six-
stranded -barrel covered with a single -helix at one end
and either a short helix or a loop at the other end. The HI-
RAN structure does not appear to be an entirely new fold
since it displays some similarity with other protein struc-
tures such as Small protein B, which binds tmRNA. Fur-
thermore, the HIRAN structure also shows a weak struc-
tural similarity to the DNA recognition domains of a couple
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structural comparisons of the HIRAN domain hint that it
may bind nucleic acids.
To gain more insight into the structure of the HI-
RAN domain, we solved the crystal structure of the frag-
ment hHLTF.56–175 (PDBID deposition 5BNH). The crys-
tal structure of hHLTF.56–175 reveals a six-stranded -
barrel covered with two -helices (Figure 1C). Interestingly,
our crystal structure revealed a dinucleotide fragment that
serendipitously co-crystallized with the HIRAN domain.
The DNA binding site of the HIRAN domain is positioned
in a cavity region formed by two loops and one -strand.
Intriguingly, this cavity, bordered by Y72 and Y93, can
accommodate only one dinucleotide (single-stranded). HI-
RAN residues Y72 and Y93 provide further stacking inter-
actions with the dinucleotide bases. We surmise that the dis-
tance between the tyrosines 72 and 93 acts as a ruler for this
dinucleotide recognition (see Figure 1C). Given the high
resolution of the crystal structure, 1.7 Å, we could identify
with certainty that the dinucleotide is constituted from T
and G. We suppose that the DNA fragment was co-purified
with the HIRAN during the purification protocol. To as-
certain the importance of this large cavity, which has the
highest amino-acid conservation level, we mutated the 70,
71, 90, 91, 110, 90/110, 91/110, and 90/91 residues of HI-
RAN to alanine and tested the functional consequences,
which revealed that only the 90/91 double mutation im-
paired fully the HIRAN function (see later in the text and
data not shown).
The HIRAN domain is indispensable for the cellular function
of HLTF
Work in our and other laboratories revealed that the RING
finger domain of HLTF is associated with ubiquitin ligase
activity for PCNA polyubiquitylation, whereas the helicase
domain facilitates dsDNA translocase activity; however, no
function has been described for the HIRAN domain. To test
the importance of the HIRAN domain in HLTF function,
we generated a HIRAN deletion, HLTF156-1009, as well as
a HIRAN point mutant, HLTF NN90,91AA, in addition to
our previously described RING mutant, HLTF C759S, and
ATPase mutant, HLTF DE557,558AA. To reveal the conse-
quences of these mutations for the in vivo function of HLTF,
we compared the UV sensitivity of HLTF shRNA knock-
down cells expressing mutant or wild-type HLTF proteins.
For this purpose, we generated stable HLTF shRNA knock-
down cell lines, in which wild-type, HIRAN-mutant, AT-
Pase mutant, or RING mutant HLTF proteins were ex-
pressed from shRNA-resistant constructs for complemen-
tation and measured their UV sensitivities (Figure 1D and
Supplementary Figure S1). As expected, the HLTF-silenced
cells were sensitive to UV irradiation, and wild-type HLTF
was able to complement this effect. However, expression of
the ATPase-mutant or the RING-mutant HLTF lowered
the sensitivity of knockdown cells less than the wild-type
HLTF, reflecting that the DNA translocase and ubiquitin
ligase activities of HLTF are important determinants of the
cellular function of HLTF, which is in line with our ear-
lier suggestion. Importantly, the expression of HLTF lack-
ing the HIRAN domain or point mutated in the HIRAN
domain did not complement the sensitivity of the HLTF
knockdown cells (Figure 1D). To rule out the possibility of
the HIRAN deletion preventing HLTF nuclear localisation,
we compared the localization of the wild-type, the HIRAN
deletion mutant and the NN90,91AA mutant HLTF and
found that all of them are localized in the nucleus (Supple-
mentary Figure S2). In sum, our findings support the idea
that the HIRAN domain of HLTF has an essential cellu-
lar role in the prevention of the deadly consequences of UV
irradiation.
The postreplication repair function of HLTF and its depen-
dence on the HIRAN domain
To gain further insight into the role of HLTF and to as-
certain the functional importance of its HIRAN domain,
we aimed to carry out a more specific in vivo assay reflect-
ing specifically the replication of damaged DNA. It is well
documented that stalling of replication at unrepaired DNA
lesions can result in discontinuities in the newly synthesized
DNA. To overcome these discontinuities, cells have evolved
mechanisms collectively referred to as postreplication repair
indicating that they can also operate after the majority of
DNA has been replicated and not only in the S-phase but
in the G2-phases as well. To unravel the role of HLTF in
postreplication repair, we used our earlier developed PRR
method, which is based on the principle that if the newly
replicating DNA is pulse labeled for a short period with
BrdU, a thymidine analog, the maturation of the newly
replicated DNA and the discontinuities left in the newly
synthesized DNA can be measured using alkaline comet as-
say. The nascent DNA fragments can be separated from the
template strand by alkaline unwinding and electrophoresis
and visualized as comet tail DNA after immunostaining of
the incorporated BrdU (Figure 2). If the replication process
was undisturbed, after a six-hour chase period following
BrdU labelling, the elongating DNA ends synthesized from
neighbouring replicons abut and are sealed by DNA ligase,
resulting in a continuous nascent DNA that remains in the
comet head (Figure 2B and C). However, after UV irradia-
tion, when replication fork movement is inhibited and DNA
elongation is blocked, the newly synthesized DNA remains
partially fragmented, indicated by the appearance of about
20 percent of the nascent strand DNA in the comet tail
after a 6-hour chase period in wild-type cells (Figure 2C).
Importantly, after UV irradiation, DNA maturation was
more strongly inhibited in stable HLTF shRNA-silenced
cells than in wild-type cells, as revealed by the increase in
the percentage of comet tail DNA to 45 percent, suggesting
a postreplication repair function for HLTF. This effect is at-
tributed to the absence of the HLTF protein, since express-
ing wild-type shRNA-resistant HLTF in shRNA knock-
down cells significantly restored DNA maturation. By con-
trast, the expression of the HIRAN deletion mutant or the
NN90,91AA point mutant shRNA-resistant HLTF was not
able to complement HLTF-silenced cells indicating that the
HIRAN domain is essential for the postreplication repair
function of HLTF. In contrast to damaged cells, in undam-
aged cells we found no difference in DNA maturation in the
absence or presence of mutant or wild-type HLTF proteins,
suggesting that HLTF specifically functions in the replica-
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Figure 2. HLTF-mediated postreplication repair depends on the HIRAN domain. (A) Experimental setup of alkaline BrdU comet postreplication repair
assay. Cells were first pulse-labeled with BrdU for 20 min, washed with PBS and UV-irradiated or mock-treated, followed by chasing by adding 4× dNTP
for 6 hours before alkaline single cell electrophoresis. (B) Representative images of the UV-treated cells after comet assay. HLTF was stably depleted in
HCT116 cells by shRNA, and for testing complementation the shRNA-resistant form of WT (HLTF WT) or HIRAN mutant HLTF 156–1009 or HLTF
NN90,91AA expressing plasmids were transfected transiently. (C) Representation of the percentage of comet tail DNA without and after UV treatment.
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The HIRAN domain is dispensable for the ubiquitin lig-
ase, ATPase, and dsDNA translocase enzymatic activities of
HLTF
To gain a biochemical explanation for the critical role of
the HIRAN domain of HLTF in PRR, we purified the
HLTF156–1009 protein completely lacking the N-terminal
HIRAN domain and the point mutant HLTF NN90,91AA
protein (Figure 3A). To test the effect the deletion or point
mutation of HIRAN has on the basic biochemical proper-
ties of HLTF, we compared mutant and wild-type HLTF
proteins in ATPase, ubiquitin ligase, and dsDNA translo-
case assays. We found that the HIRAN mutation did not
affect the dsDNA-dependent ATPase activity of HLTF,
as shown by the amount of released gamma-phosphate
groups of ATP visualized by thin layer chromatography
(Figure 3B). To detect the PCNA polyubiquitin ligase ac-
tivity of HLTF, we loaded PCNA on circular plasmid DNA
by RFC, followed by the addition of purified ubiquitin,
E1, Rad6-Rad18, and Mms2-Ubc13 E2 enzymes along with
wild-type or mutant HLTF and followed the reaction via
Western-blot using anti-PCNA antibody. We found that the
ubiquitin ligase activity of HIRAN mutant HLTF is as ef-
ficient as that of the wild-type protein (Figure 3C). For
the dsDNA translocase assay, we generated a partial three-
stranded DNA substrate, on whose dsDNA region HLTF
can initiate translocation leading to the release of a ss-
DNA oligonucleotide. We established that HLTF HIRAN
mutants retained a significant dsDNA translocase activity
as compared to the wild-type HLTF (Figure 3D). Thus,
we conclude from these experiments that the NN90,91AA
point mutation or even the complete deletion of the HI-
RAN domain does not compromise the folding of HLTF
and does not affect its ubiquitin ligase and ATPase activities
while only slightly impairs its dsDNA translocase activity.
The HIRAN domain of HLTF is necessary for replication
fork regression
Having gained in vivo evidence for an essential role of the
HIRAN domain in HLTF raised the possibility that re-
moval of the HIRAN domain may change some replica-
tion fork-associated, specific enzymatic activities of HLTF.
Our previous report indicated that HLTF can regress repli-
cation forks, for which we proposed a function in the tem-
plate switching-dependent replication of damaged DNA.
To test if the HIRAN domain has a role in the fork rever-
sal activity of HLTF, we used a model replication fork sub-
strate generated by annealing synthetic oligonucleotides.
As shown in Figure 4A, fork reversal by HLTF generated
two dsDNA fragments, modelling parental and daughter
duplexes, which migrated faster than the fork on a non-
denaturing gel. Importantly, HLTF point-mutated in its HI-
RAN domain (HLTF NN90,91AA) or completely lacking
the HIRAN domain (HLTF156–1009) was not able to carry
out fork reversal indicating a crucial role for HIRAN in this
replication fork remodelling activity (Figure 4A). To rule
out the possibility of an artefact due to the short size of
the model fork DNA, fork regression assay was also car-
ried out on plasmid-based fork-like structures (Figure 4B).
To do so, we constructed a plasmid-sized model fork by an-
nealing two nearly identical plasmids, resulting in a configu-
ration where the labeled ‘lagging’ strand is longer by 14 nu-
cleotides. Conversion of this structure by fork reversal can
be conveniently followed by monitoring the transfer of the
radioactive label from the circular lagging arm to the linear
regressed arm context by using restriction endonucleases
(Figure 4B). As shown in Figure 4B, HLTF can regress the
plasmid-sized fork through hundreds of bases, since at our
longest checkpoint using AflIII restriction endonuclease, at
a length of 863 base pairs, a regressed arm appeared readily
(Figure 4B). In a parallel reaction, the HIRAN-deleted or
point-mutated proteins were impaired in the reversal of the
plasmid-based model replication fork (Figure 4B) revealing
the critical role of the HIRAN domain. To further ascertain
the crucial role of the HIRAN domain, we tested - using pu-
rified proteins - whether purified HIRAN domains can fold
together with the HIRAN-deleted HLTF156-1009 protein
and thus rescue its fork reversal deficiency. To this end, we
expressed and purified the wild-type and the 90,91 alanine
mutant HIRAN domains encompassing only amino acids
56-168 of HLTF (Figure 4C). Using an oligonucleotide-
based fork, we found that mixing the wild-type but not the
NN90,91AA HIRAN domains with the HIRAN-deleted
HLTF resulted in reconstituted fork reversal activity (Fig-
ure 4D). In summary, our results show that the HIRAN do-
main is absolutely required for the fork regression activity
of HLTF, and its two asparagines in positions 90 and 91 are
essential for this role.
The HIRAN domain of HLTF specifically binds to replica-
tion fork structures
Since deficiency in the HIRAN domain affected only fork
regression but not the ubiquitin ligase or the dsDNA-
dependent ATPase activities of HLTF, we hypothesized that
HIRAN may lend a certain specificity to replication fork
binding. To investigate this hypothesis, we tested purified
HIRAN domain, both wild-type and mutant, for binding
to various DNA substrates such as double-stranded, single-
stranded, partial double-stranded, and replication fork-like
oligonucleotide-based structures using gel retardation assay
(Figure 5A). We found that the NN90,91AA mutant HI-
RAN domain failed to bind to any of the DNA substrates.
However, the wild-type HIRAN domain exhibited a very
high affinity for single-stranded DNA substrates while no
affinity for dsDNA, and it also bound to a partial heterodu-
plex, presumably because it contained a single-stranded re-
gion (Figure 5A). Importantly, the HIRAN domain also
showed a high affinity for the replication fork structure,
which, however, had no single-stranded DNA region (Fig-
ure 5A). To further clarify the binding specificity, we carried
out a competition assay in which a Cy5-labeled replication
fork-like structure was first saturated with bound HIRAN
domain then the binding was challenged by the addition of
increasing amounts of fluorescein-labeled single-stranded
oligonucleotides or oligonucleotide-based replication-forks
(Figure 5B). We observed that the replication fork com-
peted more efficiently for HIRAN binding than did single-
stranded DNA (Figure 5B). Moreover, quantification of the
competition assay also confirmed that HIRAN bound with
a higher affinity to the fork than to ssDNA (Figure 5C).
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Figure 3. The effect of HIRAN point mutation or deletion on the enzymatic function of HLTF. (A) Purity of the FLAG-tagged wild-type (HLTF WT),
HIRAN deletion (HLTF156–1009), and point mutant (HLTF NN90,91AA) proteins. Purified proteins were run on 8% denaturing polyacrylamide gel and
stained with Coomassie blue. (B) Mutation of the HIRAN domain of HLTF does not compromise its ATPase activity. [ -32P]ATP was incubated with
increasing concentrations of wild-type, HIRAN domain-deleted, and HIRAN point mutant HLTF proteins in the presence of 75-mer double-stranded
oligonucleotides. Hydrolyzed gamma-phosphate (Pi) was detected by thin layer chromatography. (C) Mutation of the HIRAN domain of HLTF does
not affect its ubiquitin ligase function. PCNA was first loaded onto nicked plasmid DNA by RFC, followed by adding ubiquitin, Uba1, Rad6-Rad18,
Mms2-Ubc13 and wild-type, HIRAN domain-deleted or HIRAN domain point mutant purified HLTF proteins. Ubiquitylation of PCNA was followed
by western blot using anti-PCNA antibody. (D) Mutation of the HIRAN domain of HLTF does not affect its double-stranded DNA translocase activity.
Radioactively labeled triple-helix substrate was incubated with increasing amounts of wild-type, HIRAN-deleted or HIRAN domain point mutant HLTF
proteins, and the release of single-stranded DNA products was followed by native polyacrylamide gel electrophoresis.
stranded DNA, the HIRAN domain exhibits structure-
specific binding to replication fork-like DNA structures.
DISCUSSION
Previous studies revealed that HLTF is frequently inacti-
vated in many tumours, indicating that loss of HLTF func-
tion promotes carcinogenesis (22,40). In concert with its po-
tential tumour suppressor function, experiments performed
by our group and others defined HLTF as a replication
stress response protein that specifically acts during the repli-
cation of damaged DNA and contributes to error-free dam-
age tolerance (19–21,24–26). We now report that HLTF
plays a critical role in filling in the gaps remaining oppo-
site the damaged DNA after the majority of DNA has been
replicated, but its depletion does not slow down the over-
all rate of DNA maturation during the replication of un-
damaged DNA. We found that that the HIRAN domain of
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Figure 4. The HIRAN domain is necessary for HLTF fork regression activity. (A) Fork regression activity of HLTF on oligonucleotide-based replica-
tion fork-like structure. Increasing amounts of wild-type (HLTF WT), HIRAN deletion mutant (HLTF 156–1009), or HIRAN point mutant (HLTF
NN9,91AA) HLTF were incubated with a radioactively labeled oligonucleotide-based replication fork-like structure. The release of the parental (75-mer)
and daughter duplexes (30-mer) as products of fork regression were followed by electrophoresis on nondenaturing polyacrylamide gel. (B) Schematic
representation of the plasmid-based model replication fork substrate used for testing HLTF fork regression activity. Fork regression activity of purified
wild-type (HLTF WT), HIRAN-deleted (HLTF 156-1009), and HIRAN point mutant (NN90,91AA) HLTF proteins on radioactively labeled plasmid-
based replication fork-like structure. Fork regression was revealed by digesting the products with restriction endonucleases BamHI (B), EcoRI (E) and
AflIII (A). (C) Schematic representation and purity of wild-type and mutant HIRAN domain fragments. (D) Restoration of the fork regression activity of
the HIRAN-deleted HLTF156-1009 protein by purified HIRAN domain fragment (containing only the 56–168 residues of HLTF). Purified wild-type or
point mutant HIRAN domains were mixed with HIRAN-deleted HLTF156-1009 proteins and assayed for fork reversal activity using fluorescently labeled
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Figure 5. The HIRAN domain specifically binds to a replication fork-like structure. (A) Gel-retardation assay to reveal the binding of HLTF to various
DNA substrates. Purified wild-type or mutant HIRAN domains were incubated with dsDNA, ssDNA, partial heteroduplex, and replication fork-like
oligonucleotide-based DNA substrates before electrophoresis on nondenaturing acrylamide gels. (B) DNA competition assay. Purified HIRAN domain
was preincubated with oligonucleotide-based Cy5-labeled replication fork-like substrate, followed by adding fluorescently labeled competitor ssDNA or
replication fork substrates in the same increasing concentrations. After electrophoresis, the same gel was visualized first for Cy5 (upper panel) and next for
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revealed that the HIRAN domain can specifically bind to
the junction of a replication fork-like DNA structure, and
it provides the direction for the dsDNA translocase motor
domain toward the junction, which is required for HLTF-
mediated fork reversal. As further support, we show that
while HIRAN-deleted HLTF has dsDNA translocase activ-
ity it does not exhibit fork reversal activity and that adding
the purified HIRAN fragment can complement the fork re-
versal activity of HIRAN-deleted HLTF. We also solved
the X-ray structure of HIRAN bound to a dinucleotide
and present a molecular model of how HLTF enables DNA
damage bypass and replication restart.
Replication fork maintenance pathways preserve chro-
mosome integrity; their impaired operation may generate
genome rearrangements and lead to genomic disorders.
Whereas in yeasts template switching is known to play an
important role in DNA damage bypass - besides transle-
sion DNA synthesis -, the degree to which template switch-
ing contributes to the above process in mammalian cells is
less known, and the participants are still being identified.
Although several studies confirmed the key regulatory role
of the RAD6-RAD18-catalyzed ubiquitylation of the repli-
cation clamp PCNA in mammalian PRR, the effector com-
ponents of the error-free PRR pathway remained unknown
(2,4,7,39). To our knowledge, our present study on HLTF
is the first to give direct evidence for a role of a fork reversal
enzyme in mammalian PRR.
Although recent evidence confirmed that replication
forks can be reversed resulting in ‘chicken foot’ structures,
the physiological role of these structures is still debated
(7,34). On the one hand, fork reversal was proposed to trig-
ger nucleolytic processing of the fork particularly in the ab-
sence of normal checkpoint response. On the other hand,
some authors suggested that reversal might actually pro-
tect the fork from being processed into DSB (32,41,42). Ev-
idently, further studies are required to reveal the circum-
stances in which the formation of reversed forks is patholog-
ical and in which it is protective. Our data point to a protec-
tive role for HLTF-dependent fork reversal during the repli-
cation of damaged DNA; however, similar studies would be
essential to test the interplay between other fork reversal en-
zymes such as SMARCAL1, ZRANB3, FANCM, WRN,
BLOOM, and Rad54 and their contribution to PRR.
The HIRAN structure we present is basically consistent
with the structures reported recently and they are in agree-
ment regarding HIRAN as a DNA-binding domain (28,29).
However, it was reported that the HIRAN domain specif-
ically recognizes the 3′-end in a partial heteroduplex DNA
and can even bind to dsDNA. In contrast, our data show
that HIRAN has a high affinity for ssDNA, but it cannot
bind dsDNA, and, more importantly, HIRAN displays a
preferential affinity for replication fork-like junctions. The
explanation for this difference may lie in our more stringent
assay conditions for HIRAN-DNA binding, since we used a
higher ionic strength buffer, which resembled physiological
conditions more closely. The ability of HIRAN to preferen-
tially bind to replication fork-like junctions that completely
lacked single-stranded regions was unexpected, since HI-
RAN has no affinity for dsDNA. We suggest that this speci-
ficity of HIRAN is critical for the facilitation of the correct
positioning of the HLTF motor domain to the parental ds-
DNA region of the fork.
Like other SF2 helicases/translocases, HLTF is com-
posed of two RecA-like domains that form an ATP-
dependent motor enabling translocation of the protein
along the dsDNA. On the other hand, the N-terminal HI-
RAN domain specifically determines the high affinity of
HLTF for branched DNA structures and its ability to per-
form reversal of the replication fork. Importantly, our re-
sults indicate that HIRAN is essential only for the fork re-
versal activity of HLTF, but is not required for the ubiq-
uitin ligase, DNA-dependent ATPase, and dsDNA translo-
case activities. From the ability of HIRAN-deleted HLTF to
displace the third strand of a partial triple-stranded DNA,
we conclude that HIRAN does not directly affect the mo-
tor domain of HLTF. Instead, we suggest that HIRAN pro-
vides specificity to the action of the motor domain by deter-
mining the direction for dsDNA translocation toward the
junction, thereby converting the energy of ATP hydrolysis
into strand separation, annealing of the daughter strands,
and branch migration in the course of fork reversal. In addi-
tion to binding to the junction point and thus orienting the
movement of the ATPase motor, HIRAN may also serve as
a wedge at the branch point (Figure 6).
There are a number of other SF2 helicases/translocases
that participate in the reversal of collapsed replication forks
but none of them contain the HIRAN domain. For ex-
ample, in bacterial RecG the corresponding N-terminal
‘wedge’ domain is represented by an OB-fold domain (43).
Both HIRAN and OB domains are closed -barrels, but
they differ in the number of strands in a barrel: HIRAN has
six while the OB-domain has five -strands. Neither three-
dimensional structures nor sequences reveal the significant
similarity between the two domains. On the other hand, HI-
RAN lacking the N-terminal -strand has the same topol-
ogy as the canonical OB-fold including the position of the
-helix capping the -barrel (Supplementary Figure S3).
Therefore, at present it is unclear whether HIRAN is evolu-
tionary unrelated to the OB-fold or has originated from the
latter as a result of the addition of the N-terminal strand
and its invasion into the -barrel. Interestingly, HIRAN
and OB domains are not the only determinants of the fork
reversal function in SF2 proteins. Another domain found to
be important for this function is the HARP domain. Two
HARP domains are present in SMARCAL1, a DNA re-
modelling protein fundamental to genome integrity during
replication, and a single HARP domain is found at the N-
terminus of the T4 fork regression enzyme UvsW (44). The
HARP domain represents a compact globular fold which
consists of a five-stranded -sheet packed against two -
helices and thus is not even remotely similar to either the
OB or the HIRAN domains. The collection of ‘wedge’ do-
mains is further extended by the -helical domain struc-
turally similar to the ‘thumb’ domain of DNA polymerase
(45). This domain, playing a critical role in fork recognition,
was first identified as an insertion between RecA-like do-
mains in the archaeal Hef helicase. A similar domain is also
present in FANCM. To further broaden the range, RecQ-
like SF2 helicases BLM and WRN add to the collection yet
another domain, the winged-helix (WH) domain within the
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Figure 6. Schematic representation of the function of HIRAN. (A) Without the HIRAN domain, HLTF cannot be positioned at the junction point of a
replication fork; although it can translocate on the dsDNA region, the junction and the two arms present a barrier for translocation into that direction.
These reasons explain why HIRAN-mutated HLTF is able to displace ssDNA from a partial triple helix DNA but is unable to carry out fork reversal.
(B) The HIRAN domain of HLTF can provide direct binding for HLTF to the junction point of the fork; serve as a pin for separating the two strands of
parental/daughter dsDNA arms; orient the dsDNA translocase activity of HLTF into the right direction toward the junction. These reasons explain the
critical role of HIRAN in HLTF-mediated fork reversal enabling its cellular function.
(RQC) (46,47). Compiling the results regarding these spe-
cific domains of fork reversal enzymes and our finding that
HIRAN-deleted HLTF loses its fork reversal activity but
retains its dsDNA translocase activity indicates that, per se,
the ability to translocate on dsDNA does not necessarily im-
ply fork reversal, which is a rather specific activity requiring
the specific cooperation of a motor domain and a junction-
binding domain. To further support this notion, it would be
of great interest to interchange the motor domains and the
junction-binding domains of various fork reversal enzymes
and test the resulting chimeras for their dsDNA translocase
and fork reversal activities.
In summary, our data support that HLTF is an impor-
tant player in PRR and its HIRAN domain is essential for
this function. We suggest that when sensing a replication
fork blocked by lesion, HIRAN binds to the junction of the
fork and orients the motor domain into the correct position
enabling HLTF to catalyse strand annealing and branch mi-
gration leading to fork reversal. In general terms, our find-
ings explain why only a subset of DNA translocases can
carry out fork reversal and highlight the importance of the
presence of two DNA-binding domains in these enzymes.
We conclude that in addition to the DNA-binding AT-
Pase motor domain, fork reversal enzymes should also have
a junction-specific DNA-binding domain such as the HI-
RAN, OB, HARP, or winged-helix (WH) domains. Based
on these criteria, novel fork reversal enzymes can be identi-
fied, and future research can reveal the effect of fork reversal
on DNA lesion tolerance and genome stability.
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